Gainer Oy Competitors

Wake Forest University School of Medicine directs the education of nearly 1,900 students and fellows, including physicians, basic scientists and allied clinical professionals. The School of Medicine also strategically investigates opportunities that will expand basic and clinical research, resulting in nationally and internationally recognized excellence in biomedical research. The School of Medicine seeks to leverage its current areas of strength and focus to improve integration of its research programs and to maximize multidisciplinary and translational approaches. The School of Medicine is among the top of U.S. academic medical centers in total funding from the National Institutes of Health (NIH). In the 2014 fiscal year, the school was awarded $193.4 million in research funding from federal and state agencies, industry and other sources. The School of Medicine curriculum, developed by faculty, aims to cultivate physicians who: - Set the standards for compassionate, collaborative care. - Lead the way in socially responsible health care and biomedical sciences locally, nationally, and globally. - Engage in lifelong learning, discovery and application of innovative knowledge technology and skills in medicine. The School of Medicine is committed to excellence in primary care, with students experiencing patient care from their first week of medical school, as well as tertiary care, a critical component for a research and teaching hospital.

Macquarie is a university engaged with the real and often complex problems and opportunities that define our lives. Since our foundation 60 years ago, we have aspired to be a different type of university: one unbound by ivory towers and sandstone walls. Rather, we are focused on fostering collaboration between students, academics, industry and society, encouraging all to traverse the boundaries of their own perspective and affect change.

Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. Ceribell has developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence (“AI”)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA 510(k) cleared for indicating suspected seizure activity and currently utilized in intensive care units and emergency rooms across the U.S. Ceribell is headquartered in Sunnyvale, California. Our mission is to establish the Ceribell System as the standard of care for EEG in the acute care setting and help clinicians save patient lives.